cagrisema semaglutide cagrilintide combination trial Topline data from REDEFINE 1 found CagriSema, a fixed-dose of 2.4 mg and 2.4 mg, achieved superior weight loss versus placebo in adults with obesity or overweight. 🔗https://t.co/JA9E3FpCsN #ObesityManagement # CagriSema vs Retatrutide 2026: Approval

Delivered through a weekly subcutaneous injection , these treatments can lead to clinically significant, sustainable weight loss when combined with healthy nutrition and exercise

You can only get Semaglutide GLP-1 through a healthcare provider because it is a prescription drug

A new study finds an association between semaglutide and a rare eye condition

Do I need a prescription

After these dates, the FDA will begin enforcing the normal regulatory restrictions on compounded drugs, and manufacturing or distributing compounded semaglutide injections will be considered a violation of the FD&C Act

These markers measure response